← Back to Clinical Trials
Recruiting NCT05999578

NCT05999578 Contribution of Hypnosis on Image Quality in Cardiac MRI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05999578
Status Recruiting
Phase
Sponsor University Hospital, Bordeaux
Condition Anxiety
Study Type INTERVENTIONAL
Enrollment 90 participants
Start Date 2025-04-15
Primary Completion 2027-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Hypnosis

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 90 participants in total. It began in 2025-04-15 with a primary completion date of 2027-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The present project aims to explore the effect of a hypnosis session performed on a patient with anxiety during a cardiac MRI examination on image quality.

Eligibility Criteria

Inclusion Criteria: * Anxious patient (anxiety score TRAIT (baseline) and anxiety score STATE (situational) ≥ 46) and non-anxious patient (anxiety score TRAIT and anxiety score STATE \< 46) requiring cardiac MRI for diagnosis or follow-up of a cardiac pathology except the patients with cardiac arrhythmias or irregular heartbeats. * 18 years and older * Highly effective contraception for women of childbearing potential, maintained during research procedures * Informed consent * Affiliated or beneficiary of health insurance Exclusion Criteria: * Contraindications to MRI and gadoline contrast medium * Hearing impaired patients * Patients who do not speak French * Women who are pregnant or lactating * Inability to agree to participate to the study * Patient under legal protection

Contact & Investigator

Central Contact

Amandine ANDRE-BILLEAU

✉ amandine.andre@chu-bordeaux.fr

📞 +33557820000

Frequently Asked Questions

Who can join the NCT05999578 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05999578 currently recruiting?

Yes, NCT05999578 is actively recruiting participants. Contact the research team at amandine.andre@chu-bordeaux.fr for enrollment information.

Where is the NCT05999578 trial being conducted?

This trial is being conducted at Bordeaux, France.

Who is sponsoring the NCT05999578 clinical trial?

NCT05999578 is sponsored by University Hospital, Bordeaux. The trial plans to enroll 90 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology